Back to company

ZYMENEX ApS: Financial statements 2017

CVR: 27394752

ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 39,575,000 and a net result of DKK 3,404,000 compared with DKK 294,360,000 the year before. That is a decrease of 19.3% compared with the year before. The profit margin was 8.6%. Equity amounted to DKK 80,885,000. The solvency ratio was 48%.

Revenue
39,575,000 kr.
Gross Profit
39,575,000 kr.
Profit/Loss
3,404,000 kr.
Equity
80,885,000 kr.
Total Assets
168,416,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201739.6 mio.39.6 mio.3.4 mio.80.9 mio.-
201649.1 mio.49.1 mio.294.4 mio.230.3 mio.-
2015--52.5 mio.656 t.-64.1 mio.-
2014--67.9 mio.1.1 mio.-64.8 mio.-
2013---33.8 mio.-65.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ZYMENEX ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

Mark Parry-Billings joins the board of ZYMENEX ApSJul 15, 2017

As of July 15, 2017, Mark Parry-Billings has joined the board of directors of ZYMENEX ApS.

Paolo Patri leaves the board of ZYMENEX ApSJul 15, 2017

As of July 15, 2017, Paolo Patri has left the board of directors of ZYMENEX ApS.

Mark Parry-Billings joins ZYMENEX ApS as directorJul 15, 2017

As of July 15, 2017, Mark Parry-Billings is registered as director of ZYMENEX ApS.

Paolo Patri steps down as director of ZYMENEX ApSJul 15, 2017

As of July 15, 2017, Paolo Patri has stepped down as director of ZYMENEX ApS.

ZYMENEX ApS: The 2016 annual report is outMay 1, 2017

ZYMENEX ApS has published its annual report for 2016. Revenue came to DKK 49,052,000, and the net result was DKK 294,360,000.

About ZYMENEX ApS

ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.

Other financial years